Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04245150 · ClinicalTrials.gov registry record
Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 23
- Enrollment target
NCT04245150 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 23 participants.
The verdict
NCT04245150 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Microorganisms in the human body (such as virus, bacteria, fungus) may have an important role in breast cancer side effects. In this study, microorganisms will be analyzed to determine which, if any,are present. It will then be determined if side effects from breast radiation are associated with these microorganisms. Understanding the association of microorganisms with side effects will allow the study team to look at strategies to reduce side effects for patients undergoing radiation to the breast.
Interventions
- OTHER Stool sample
- OTHER Skin Swab Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-03-21 |
| Est. Completion | 2024-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04245150
The ClinicalTrials.gov registry entry for NCT04245150 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stool sample is the first listed.
NCT04245150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04245150 about?
NCT04245150 is a clinical study titled "Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity". Microorganisms in the human body (such as virus, bacteria, fungus) may have an important role in breast cancer side effects. In this study, microorganisms will be analyzed to determine which, if any,are present. It will then be determined if side effects from breast radiation are associated with the...
What is the current status of trial NCT04245150?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2019-03-21. Estimated completion is 2024-07-30.
What interventions are being tested in trial NCT04245150?
The interventions under investigation include: Stool sample (OTHER), Skin Swab Sample (OTHER).
Who is sponsoring clinical trial NCT04245150?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.